MDT

96.57

-0.29%↓

A

147.59

+0.46%↑

VEEV

223.95

-2.66%↓

HQY

86.11

+3.25%↑

PHR.US

16.35

0%↓

MDT

96.57

-0.29%↓

A

147.59

+0.46%↑

VEEV

223.95

-2.66%↓

HQY

86.11

+3.25%↑

PHR.US

16.35

0%↓

MDT

96.57

-0.29%↓

A

147.59

+0.46%↑

VEEV

223.95

-2.66%↓

HQY

86.11

+3.25%↑

PHR.US

16.35

0%↓

MDT

96.57

-0.29%↓

A

147.59

+0.46%↑

VEEV

223.95

-2.66%↓

HQY

86.11

+3.25%↑

PHR.US

16.35

0%↓

MDT

96.57

-0.29%↓

A

147.59

+0.46%↑

VEEV

223.95

-2.66%↓

HQY

86.11

+3.25%↑

PHR.US

16.35

0%↓

Search

Stryker Corp

Open

SectorHealthcare

353.67 0.17

Overview

Share price change

24h

Current

Min

350

Max

355.83

Key metrics

By Trading Economics

Income

-25M

859M

Sales

35M

6.1B

P/E

Sector Avg

47.424

90.831

EPS

3.19

Dividend yield

0.91

Profit margin

14.182

Employees

53,000

EBITDA

-108M

1.4B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+19.08% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.91%

2.20%

Next Earnings

29 sty 2026

Next Dividend date

30 sty 2026

Next Ex Dividend date

30 mar 2026

Market Stats

By TradingEconomics

Market Cap

-8.5B

138B

Previous open

353.5

Previous close

353.67

News Sentiment

By Acuity

24%

76%

60 / 361 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Stryker Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

30 paź 2025, 20:36 UTC

Earnings

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31 lip 2025, 20:42 UTC

Earnings

Stryker Lifts Guidance on Improving Tariff Outlook

1 maj 2025, 20:56 UTC

Earnings

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

5 lis 2025, 19:38 UTC

Earnings

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 lis 2025, 17:00 UTC

Earnings

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 paź 2025, 20:21 UTC

Earnings

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q Adj EPS $3.19 >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q EPS $2.22 >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q Sales $6.1B >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q Net $859M >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q Adj EPS $3.19 >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q Net $859M >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q Sales $6.06B >SYK

30 paź 2025, 20:05 UTC

Earnings

Stryker 3Q EPS $2.22 >SYK

31 lip 2025, 20:09 UTC

Earnings

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 lip 2025, 20:09 UTC

Earnings

Stryker Sales >SYK

31 lip 2025, 20:09 UTC

Earnings

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 lip 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 lip 2025, 20:05 UTC

Earnings

Stryker 2Q Net $884M >SYK

31 lip 2025, 20:05 UTC

Earnings

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 lip 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 lip 2025, 20:05 UTC

Earnings

Stryker 2Q Adj EPS $3.13 >SYK

31 lip 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 lip 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 lip 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

1 maj 2025, 20:41 UTC

Earnings

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1 maj 2025, 20:11 UTC

Earnings

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1 maj 2025, 20:10 UTC

Earnings

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1 maj 2025, 20:05 UTC

Earnings

Stryker 1Q Adj EPS $2.84 >SYK

Peer Comparison

Price change

Stryker Corp Forecast

Price Target

By TipRanks

19.08% upside

12 Months Forecast

Average 430.32 USD  19.08%

High 465 USD

Low 390 USD

Based on 20 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

20 ratings

17

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

373.92 / 383.99Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

60 / 361 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat